ReviewNPJ primary care respiratory medicine2026
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care.
Review in NPJ primary care respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Carbon Emissions and Treatment Efficiency in Chronic Obstructive Pulmonary Disease: The Impact of Inhaled Bronchodilators and Corticosteroids.International journal of chronic obstructive pulmonary disease · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of climate change on chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease is becoming ever more apparent, with extremes of heat and cold, increased humidity, and severe weather events worsening the risk of negative outcomes in these patients, including mortality. In turn, climate change is altering the patterns and types of aeroallergens and viruses that also impact the day-to-day lives of patients with respiratory diseases. As a consequence, physicians caring for patients with chronic respiratory diseases may be especially interested in how climate change impacts these conditions and, conversely, how management of these diseases may affect the environment. In this setting, it is of note that poorly controlled respiratory diseases have a higher carbon footprint than well-controlled diseases, especially if an individual is hospitalised. Effective therapy that reduces the occurrence of symptoms and prevents exacerbations will therefore minimise the impact of a respiratory disease on the environment, regardless of the type of device used for delivery of maintenance therapy. In addition, any inhaler choice should be personalised, considering a patient's preference for, and ability to use the inhaler device correctly, but it is also important to consider the overall lifecycle carbon footprint of an inhaler, not only of the gases emitted. This narrative review summarises evidence on how climate change is impacting individuals with chronic respiratory diseases, and discusses how respiratory clinical practice can impact climate change. Importantly, we propose that the main contribution to minimising the impact of chronic respiratory diseases on the climate is to optimise disease control and self-management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.